|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 南中国海成因:右行拉分作用与左行转换挤压作用交替显示文摘总结分析了南中国海各次级盆地及其周缘有关盆地的裂谷作用序列 ,认为它们的裂谷作用序列是相似的 ,虽然存在局部差异。古近纪 (—早中新世 )和新近纪分别为一级裂谷阶段和后裂谷阶段 ,并可进一步划分次一级裂谷和后裂谷阶段。南中国海总体几何学特征及其次级盆地和周缘盆地的几何学特征表明 ,它们的裂谷作用是以近南北向主断裂为主剪切的右行拉分作用。在右行拉分过程中 ,东越南断裂的南延 (翼他陆架部分 )可能没有发生巨大脆性平移而表现为巨大的右行韧性牵引 ;印支—苏门答腊地块是被东越南断裂、东安达曼海断裂、红河断裂和苏门答腊断裂等四条断裂围限的呈菱形的右行走滑双重构造。深海盆的洋壳在许多方面与概念化大洋洋壳不同 ,相互矛盾的各种磁异常条带年龄并不可信。它的洋壳是右行拉分作用形成的洋壳。它们的后裂谷作用是以近南北向主断裂为主剪切的左行转换挤压反转变形为特征。联系到裂谷作用序列 ,南中国海成因具有右行拉分作用、裂谷作用和左行转换挤压作用交替出现的特征 ,表现了具有转换性质的“开”与“合” | 许浚远 杨巍然 曾佐勋 ZviBEN-AVRAHAM 李通艺 李兆麟 Christophe BASILE 张凌云 | 2004 | 地学前缘2004，11，3： | 11 |
| 2 | 澳大利亚人乳头状瘤病毒疫苗计划实施5年对年轻人群生殖器疣患病情况的影响:国家调查数据分析显示文摘目的评估2007年中开始的澳大利亚人乳头状瘤病毒(HPV)疫苗计划对生殖器疣患病情况的影响。设计国家调查数据趋势分析。数据来源数据收集于2004--2011年度澳大利亚8所性健康服务机构;其中2所最大的临床中心收集了自我报告的本中心2009年度HPV疫苗现状。研究对象2004--2011年度首次就诊的85770名澳大利亚出生的国民;其中7686(9.0%)名患生殖器疣。主要结局测量比较前疫苗时期(2004—2007年中)和疫苗时期(2007年中-2001年末)不同人群生殖器疣新发病率变化趋势。结果疫苗时期21岁以下和21~30岁女性诊断患有生殖器疣的比例明显下降,发病率分别从2007年度的11.5%和11.3%下降至2011年度的0.85%和3.1%,P均〈0.001。在30岁以上的女性中未发现发病率的明显下降。在21岁以下和21~30岁异性恋男性人群中疫苗时期生殖器疣的发病率较前疫苗时期明显下降,分别由2007年度12.1%和18.2%下降至2011年度2.2%和8.9%,P均〈0.001。30岁以上的异性恋男性人群中发病率无明显下降。2011年235名21岁以下女性在使用HPV疫苗后无新发生殖器疣病例。结论年轻女性生殖器疣发病率的显著下降和2011年度部分年轻女性使用疫苗后的零发病率,说明HPV疫苗获得实验室外的良好功效。异性恋男性生殖器疣发病率的显著下降可能是由于群体免疫所致。 | Hammad Ali,lecturer Basil Donovan, professor HandanWand,senior lecturer Tim R H Read, sexual health physician David G Regan,senior lecturer Andrew E Grulich, professor Christopher K FaMey, professor Rebecca J Guy, associate professor 尹婕(译) 潘凌亚(校) | 2013 | 英国医学杂志中文版2013，16，4： | 4 |
| 3 | 接受纤溶治疗的ST段抬高心肌梗死患者在经皮冠状动脉介入治疗前服用氯吡格雷的效果:PCI-CLARITY研究显示文摘背景:关于经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)前氯吡格雷预治疗的益处目前仍有争议,并且其使用亦未获得普遍认可。
目的:于新近发生ST段抬高心肌梗死(ST—segment elevation myocardial infarction,STEMI)的患者中确定PCI前氯吡格雷预治疗预防严重不良心血管事件的效果是否优于PCI时开始采用氯吡格雷治疗。
设计、地点及参试者:CLARITY(PCI—Clopidogrel as Adjunctive Reperfusion Therapy)研究是一项于1863例患者中进行的前瞻性计划分析。这些患者均于CLARITY—TIMI(Thrombolysis in Myocardial Infarction)28试验中在血管造影后实施了PCI。CLARITY—TIMI28是一项在接受纤溶治疗的患者中进行的有关氯吡格雷效果的随机、双盲、安慰剂对照试验。患者于2003年2月至2004年10月入选自23个国家的319家医院。
干预:患者服用阿斯匹林并于纤溶治疗时开始随机接受氯吡格雷(300mg负荷剂量,以后75mg,每日1次)或安慰剂,直至冠状动脉造影前为止。造影在开始研究药物后2~8天进行。接受冠脉支架的患者建议于诊断性血管造影后给予开标氯吡格雷(包括负荷剂量)。
主要观测指标:一级终点为PCI至随机分组后30天心血管死亡、MI复发或脑卒中的复合发生率。二级终点包括在PCI之前发生的MI或脑卒中以及前述随机分组后30天相关终点。
结果:氯吡格雷预治疗可显著降低PCI后心血管死亡、MI或脑卒中的发生率(34[3.6%]比58[6.2%];校正优势比[odds ratio,OR],0.54[95%CI,0.35—0.85];P=0.008)。氯吡格雷预治疗还可降低PCI前MI或脑卒中的发生率(37[4.0%]比58[6.2%];OR,0.62[95%CI,0.40~0.95];P=0.03)。总体上,氯吡格雷预治疗可导致随机分组后30天心血管死亡、MI或脑卒中显著下降(70[7.5%]比112[12.0%];校正OR,0.59[95%CI,0.43~0.81];P=0.001;所需治疗例数=23)。TIMI严重或轻微出血的发生率未显著增加((18[20%]比17[1.9%];P〉0.99)。
结论:氯吡格雷预治疗可显著降低PCI前后心血管死亡或缺血并发症,而严重或轻微出血无显著增加。这些数据为STEMI患者早期使用氯吡格雷以及接受PCI的患者常规采用氯吡格雷预治疗方案提供了进一步的支持。 | Marc S. Sabatine Christopher P.Cannon C. Michael Gibson Jose L Lopez-Sendon Gilles Montalescot Pierre Theroux Basil S. Lewis Sabina A. Murphy Carolyn H. McCabe Eugene Braunwald 李呈亿(译) | 2006 | 美国医学会杂志(中文版)2006，25，4： | 2 |
| 4 | The relative role of coalescence and interfacial tension in controlling dispersed phase size reduction during the compatibilization of polyethylene terephthalate/polypropylene blends 显示文摘 | Jean Christophe Lepers Basil D Favis Ronald J Tabar | 1997 | Journal of Polymer Science Part B: Polymer Physics1997，35，4： | 1 |
| 5 | Geodynamic evolution of the C6te D'ivoire-Ghana Transform margin:an over- view of leg 159 results显示文摘 | Christophe Basile Jean Mascle Jean Benkhelil | 1998 | Proceedings of the Ocean Drilling Pro- gram Scientific Results1998，159，： | 1 |
| 6 | Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men显示文摘 | Atish M Christopher M Basil S | 2009 | European Journal of Endocrinology2009，161，： | 1 |
| 7 | Character- ization of an Optimized Off-Diagonal GMI-Based Mag- netometer显示文摘 | Basile Dufay Sebastien Saez Christophe P | 2013 | IEEE SENSORS JOURNAL2013，13，1： | 1 |
| 8 | Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial显示文摘 | Anna Kotsia Emmanouil S. Brilakis Claes Held Christopher Cannon Gabriel P. Steg Bernhard Meier Frank Cools Marc J. Claeys Jan H. Cornel Philip Aylward Basil S. Lewis Douglas Weaver Gunnar Brandrup-Wognsen Susanna R. Stevens Anders Himmelmann Lars Wallenti | 2014 | American Heart Journal2014，，： | 1 |
| 9 | Long-term bene- fits of testosterone replacement therapy on angina thresh old and at hero ma in men显示文摘 | Atish M Christopher M Basil S | | European Journal of Endo- crinology 2 3090，161，： | 1 |
| 10 | Qualitative and quantitative evaluation of MODIS satellite sensor data for regional and urban scale air quality显示文摘 | Jill A. Engel-Cox Christopher H. Holloman Basil W. Coutant Raymond M. Hoff | 2004 | Atmospheric Environment2004，，16： | 1 |
| 11 | Spatial distribution of insecticide resistant Check update populations of Aedes aegypti and Ae. albopictus and first detection of V410L mutation in Ae. aegypti from Cameroon显示文摘Background:Dengue(DENV),chikungunya(CHIKV)and Zika virus(ZIKV),are mosquito-borne viruses of medical importance in most tropical and subtropical regions.Vector control,primarily through insecticides,remains the primary method to prevent their transmission.Here,we evaluated insecticide resistance profles and identifed important underlying resistance mechanisms in populations of Aedes aegypti and Ae.albopictus from six different regions in Cameroon to pesticides commonly used during military and civilian public health vector control operations.Methods:Aedes mosquitoes were sampled as larvae or pupae between August 2020 and July 2021 in six locations across Cameroon and reared until the next generation,G1.Ae.aegypti and Ae.albopictus adults from G1 were tested following World Health Organization(WHO)recommendations and Ae.aegypti GO adults screened with real time melting curve qPCR analyses to genotype the F1534C,V1016l and V410L Aedes kdr mutations.Piperonyl butoxide(PBO)assays and real time qPCR were carried out from some cytochrome p450 genes known to be involved in metabolic resistance.Statistical analyses were performed using Chi-square test and generalized linear models.Results:Loss of susceptibility was observed to all insecticides tested.Mortality rates from tests with 0.25%permethrin varied from 24.27%to 85.89%in Ae.aegypti and from 17.35%to 68.08%in Ae.albopictus.Mortality rates for 0.03%deltamethrin were between 23.30%and 88.20%in Ae.aegypti and between 69.47%and 84.11%in Ae.albopictus.We found a moderate level of resistance against bendiocarb,with mortality rates ranging from 69.31%to 90.26%in Ae.aegypti and from 86.75%to 98.95%in Ae.albopictus.With PBO pre-exposure,we found partial or fully restored suscepti bility to pyrethroids and bendiocarb.The genes Cyp9M6F88/87 and Cyp9J10 were overexpressed in Ae.aegypti populations from Douala sites resistant to permethrin and deltamethrin.Cyp6P12 was highly expressed in alphacypermethrin and permethrin resistant Ae.albopictus samples.F1534C and V1016l mutations were detected in A.aegypti mosquitoes and for the first time V410L was reported in Cameroon.Conclusions:This study revealed that Ae.aegypti and Ae albopictus are resistant to multiple insecticide classes with multiple resistance mechanisms implicated.These findings could guide insecticide use to control arbovirus vectors in Cameroon. | Matthew Montgomery James F.Harwood Aurelie P.Yougang Theodel A.Wilson-Bahun Armel N.Tedjou Christophe Rostand Keumeni Auston Marm Kilpatrick Charles S.Wondj Basile Kamgang | 2022 | Infectious Diseases of Poverty2022，11，4： | 1 |
| 12 | Stability Study of a Mixed Islanded Power Network显示文摘 | Antonio Carlos Padoan Jr. Christophe Nicolet Basile Kawkabani Jean-Jacques Simond Alexander Schwery Francois Avellan | 2014 | Journal of Energy and Power Engineering2014，8，8： | 0 |
| 13 | Stability Study on Hydroelectric Production Site Using Eigenvalues Analysis Method显示文摘 | Pedro Camilo de Oliveira e Silva Basile Kawkabani Sébastien Alligné Christophe Nicolet Jean-Jacques Simond Francois Avellan | 2012 | Journal of Energy and Power Engineering2012，6，6： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员